Emerging pharmacological therapies for ARDS: COVID-19 and beyond. (2020)
Attributed to:
Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung injury to Reduce Pulmonary dysfunctio
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00134-020-06141-z
PubMed Identifier: 32654006
Publication URI: http://europepmc.org/abstract/MED/32654006
Type: Journal Article/Review
Volume: 46
Parent Publication: Intensive care medicine
Issue: 12
ISSN: 0342-4642